Josefina Marin1, María Laura Acosta Felquer1, Leandro Ferreyra Garrot1, Santiago Ruta1, Javier Rosa1, Enrique R Soriano2. 1. From the Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires; University Institute from Hospital Italiano de Buenos Aires; Fundación Dr. Pedro M. Catoggio para el Progreso de la Reumatología, Buenos Aires, Argentina.J. Marin, MD, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, and the University Institute from Hospital Italiano de Buenos Aires; M.L. Acosta Felquer, MD, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, and the University Institute from Hospital Italiano de Buenos Aires; L. Ferreyra Garrot, MD, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, and the University Institute from Hospital Italiano de Buenos Aires; S. Ruta, MD, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, and the University Institute from Hospital Italiano de Buenos Aires; J. Rosa, MD, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, and the University Institute from Hospital Italiano de Buenos Aires, and Fundación Dr. Pedro M. Catoggio para el Progreso de la Reumatología; E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, and the University Institute from Hospital Italiano de Buenos Aires, and Fundación Dr. Pedro M. Catoggio para el Progreso de la Reumatología. 2. From the Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires; University Institute from Hospital Italiano de Buenos Aires; Fundación Dr. Pedro M. Catoggio para el Progreso de la Reumatología, Buenos Aires, Argentina.J. Marin, MD, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, and the University Institute from Hospital Italiano de Buenos Aires; M.L. Acosta Felquer, MD, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, and the University Institute from Hospital Italiano de Buenos Aires; L. Ferreyra Garrot, MD, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, and the University Institute from Hospital Italiano de Buenos Aires; S. Ruta, MD, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, and the University Institute from Hospital Italiano de Buenos Aires; J. Rosa, MD, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, and the University Institute from Hospital Italiano de Buenos Aires, and Fundación Dr. Pedro M. Catoggio para el Progreso de la Reumatología; E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, and the University Institute from Hospital Italiano de Buenos Aires, and Fundación Dr. Pedro M. Catoggio para el Progreso de la Reumatología. enrique.soriano@hospitalitaliano.org.ar.
Abstract
OBJECTIVE: To evaluate components of the minimal disease activity (MDA) criteria in psoriatic arthritis (PsA). METHODS: In patients achieving and not achieving MDA, fulfillment of each of the 7 criteria was evaluated. RESULTS: Among 41 patients with MDA, 7.4% did not fulfill the tender/swollen joint count whereas 49% did not fulfill the skin criteria. Of the 42 patients not fulfilling MDA, 100%, 76.5%, and 65% did not fulfill the patient pain score, the patient's global assessment, and the Psoriasis Area and Severity Index (PASI), respectively. CONCLUSION: A minority of patients with PsA fulfilling the MDA criteria presented active joints, but half had active skin. Visual analog scale scores and the PASI prevented patients from achieving MDA.
OBJECTIVE: To evaluate components of the minimal disease activity (MDA) criteria in psoriatic arthritis (PsA). METHODS: In patients achieving and not achieving MDA, fulfillment of each of the 7 criteria was evaluated. RESULTS: Among 41 patients with MDA, 7.4% did not fulfill the tender/swollen joint count whereas 49% did not fulfill the skin criteria. Of the 42 patients not fulfilling MDA, 100%, 76.5%, and 65% did not fulfill the patientpain score, the patient's global assessment, and the Psoriasis Area and Severity Index (PASI), respectively. CONCLUSION: A minority of patients with PsA fulfilling the MDA criteria presented active joints, but half had active skin. Visual analog scale scores and the PASI prevented patients from achieving MDA.
Authors: Philip J Mease; Arthur Kavanaugh; Laura C Coates; Iain B McInnes; Maja Hojnik; Ying Zhang; Jaclyn K Anderson; Alexander P Dorr; Dafna D Gladman Journal: RMD Open Date: 2017-07-18